Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Anandamide
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kohro S et al. | Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome. | 2004 | Anaesth Intensive Care | pmid:15675223 |
Kelley BG and Thayer SA | Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. | 2004 | Eur. J. Pharmacol. | pmid:15288572 |
McFarland MJ et al. | A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. | 2004 | J. Biol. Chem. | pmid:15292270 |
Lazzarin N et al. | Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. | 2004 | Gynecol. Endocrinol. | pmid:15293893 |
Do Y et al. | Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. | 2004 | J. Immunol. | pmid:15294950 |
Blázquez C et al. | Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. | 2004 | Cancer Res. | pmid:15313899 |
O'Sullivan SE et al. | Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. | 2004 | Br. J. Pharmacol. | pmid:15148250 |
Parkkari T et al. | Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives. | 2004 | Bioorg. Med. Chem. Lett. | pmid:15149681 |
Pacher P et al. | Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. | 2004 | J. Physiol. (Lond.) | pmid:15121805 |
Van Der Stelt M and Di Marzo V | Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. | 2004 | Eur. J. Biochem. | pmid:15128293 |
Randall MD et al. | The complexities of the cardiovascular actions of cannabinoids. | 2004 | Br. J. Pharmacol. | pmid:15131000 |
Huitron-Resendiz S et al. | Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. | 2004 | Sleep | pmid:15453543 |
Cernak I et al. | The "dark side" of endocannabinoids: a neurotoxic role for anandamide. | 2004 | J. Cereb. Blood Flow Metab. | pmid:15129189 |
Piomelli D | The endogenous cannabinoid system and the treatment of marijuana dependence. | 2004 | Neuropharmacology | pmid:15464150 |
Fernández-Rodriguez CM et al. | Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. | 2004 | Liver Int. | pmid:15482346 |
RodrÃguez de Fonseca F | [The endocannabinoid system and food intake control]. | 2004 Apr-Jun | Rev Med Univ Navarra | pmid:15382609 |
Mechoulam R | The promise of advances in the field of endocannabinoids. | 2004 Feb-Apr | Neuro Endocrinol. Lett. | pmid:15159675 |
Fride E | The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. | 2004 Feb-Apr | Neuro Endocrinol. Lett. | pmid:15159678 |
Russo EB | Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? | 2004 Feb-Apr | Neuro Endocrinol. Lett. | pmid:15159679 |
Guo Y et al. | N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. | 2005 | J. Biol. Chem. | pmid:15890658 |
Kaplan BL et al. | Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. | 2005 | Toxicol. Appl. Pharmacol. | pmid:15893538 |
van der Stelt M et al. | A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. | 2005 | FASEB J. | pmid:15894565 |
Vandevoorde S and Fowler CJ | Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. | 2005 | Br. J. Pharmacol. | pmid:15895107 |
Hillard CJ and Jarrahian A | Accumulation of anandamide: evidence for cellular diversity. | 2005 | Neuropharmacology | pmid:15910883 |
Jia Y et al. | TRPV1 receptor: a target for the treatment of pain, cough, airway disease and urinary incontinence. | 2005 | Drug News Perspect. | pmid:15915217 |
Ahern GP et al. | Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. | 2005 | J. Neurosci. | pmid:15917451 |
Glass M et al. | Misidentification of prostamides as prostaglandins. | 2005 | J. Lipid Res. | pmid:15863842 |
Osei-Hyiaman D et al. | Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. | 2005 | J. Clin. Invest. | pmid:15864349 |
Siegmund SV et al. | Anandamide induces necrosis in primary hepatic stellate cells. | 2005 | Hepatology | pmid:15841466 |
Ortega-Gutiérrez S et al. | Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. | 2005 | Glia | pmid:15920730 |
Bari M et al. | Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. | 2005 | J. Neurosci. Res. | pmid:15920744 |
Gavva NR et al. | AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15615864 |
Myrdal SE and Steyger PS | TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. | 2005 | Hear. Res. | pmid:15925202 |
Pisani A et al. | High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. | 2005 | Ann. Neurol. | pmid:15852389 |
Venderova K et al. | Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. | 2005 | Exp. Neurol. | pmid:15899265 |
Monteleone P et al. | Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. | 2005 | Neuropsychopharmacology | pmid:15841111 |
Price TJ et al. | A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. | 2005 | Neuropharmacology | pmid:15992578 |
Taddei S | Evolving the concept of regulation of vascular tone in humans. | 2005 | Br. J. Pharmacol. | pmid:15997231 |
Hohmann AG et al. | An endocannabinoid mechanism for stress-induced analgesia. | 2005 | Nature | pmid:15973410 |
Glaser ST et al. | Anandamide transport: a critical review. | 2005 | Life Sci. | pmid:15979096 |
Ambrosi S et al. | On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity. | 2005 | J. Lipid Res. | pmid:15961786 |
Tian X et al. | The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. | 2005 | J. Biol. Chem. | pmid:15964843 |
Sancho R et al. | Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. | 2005 | J. Immunol. | pmid:16148147 |
Ueda N et al. | N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines. | 2005 | Life Sci. | pmid:15949819 |
Fezza F et al. | Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. | 2005 | Anal. Biochem. | pmid:15766717 |
Ho WS and Hillard CJ | Modulators of endocannabinoid enzymic hydrolysis and membrane transport. | 2005 | Handb Exp Pharmacol | pmid:16596775 |
Elphick MR and Egertová M | The phylogenetic distribution and evolutionary origins of endocannabinoid signalling. | 2005 | Handb Exp Pharmacol | pmid:16596778 |
Wiley JL et al. | Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. | 2005 | Eur. J. Pharmacol. | pmid:15740725 |
Kraft B and Kress HG | Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids. | 2005 | J. Pharmacol. Exp. Ther. | pmid:16055676 |
Poblete IM et al. | Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. | 2005 | J. Physiol. (Lond.) | pmid:16081483 |
Mishima K et al. | Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. | 2005 | Stroke | pmid:15845890 |
Justinova Z et al. | The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. | 2005 | J. Neurosci. | pmid:15944392 |
Maccarrone M et al. | Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. | 2005 | J. Cell. Sci. | pmid:16144868 |
Chen P et al. | Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. | 2005 | Microvasc. Res. | pmid:15797258 |
Randall MD | The cardiovascular actions of anandamide: more targets? | 2005 | Br. J. Pharmacol. | pmid:15834438 |
Yang W et al. | Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. | 2005 | J. Lipid Res. | pmid:16150817 |
Kwolek G et al. | Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. | 2005 | Br. J. Pharmacol. | pmid:15834445 |
Gasperi V et al. | Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. | 2005 | Neurotoxicology | pmid:16154199 |
Mestre L et al. | Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. | 2005 | J. Neurochem. | pmid:15748152 |
Sun YX et al. | Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. | 2005 | Biochim. Biophys. Acta | pmid:16154384 |
Domenicali M et al. | Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. | 2005 | Gut | pmid:15753538 |
Barun S et al. | Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. | 2005 | Clin. Exp. Pharmacol. Physiol. | pmid:16173925 |
Bazinet RP et al. | Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. | 2005 | Neurochem. Res. | pmid:16176062 |
Oz M et al. | Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes. | 2005 | Arch. Biochem. Biophys. | pmid:15639235 |
Straiker A and Mackie K | Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. | 2005 | J. Physiol. (Lond.) | pmid:16179366 |
Engeli S et al. | Activation of the peripheral endocannabinoid system in human obesity. | 2005 | Diabetes | pmid:16186383 |
Underdown NJ et al. | Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. | 2005 | Br. J. Pharmacol. | pmid:16158067 |
Maccarrone M et al. | Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. | 2005 | Mol. Hum. Reprod. | pmid:15563449 |
Mechoulam R | Plant cannabinoids: a neglected pharmacological treasure trove. | 2005 | Br. J. Pharmacol. | pmid:16205721 |
Wang Y et al. | VR1-mediated depressor effects during high-salt intake: role of anandamide. | 2005 | Hypertension | pmid:16144988 |
Thomas A et al. | Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. | 2005 | Br. J. Pharmacol. | pmid:16205722 |
Patel S et al. | The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. | 2005 | J. Lipid Res. | pmid:15576840 |
Fegley D et al. | Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15579492 |
Li C et al. | High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. | 2005 | J. Med. Chem. | pmid:16190768 |
Valenti M et al. | The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. | 2005 | J. Neurochem. | pmid:16135090 |
Matsuda K et al. | The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. | 2005 | Tohoku J. Exp. Med. | pmid:16141678 |
Rossato M et al. | Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15562018 |
Suplita RL et al. | Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. | 2005 | Neuropharmacology | pmid:16129456 |
Osei-Hyiaman D et al. | Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. | 2005 | Neuroendocrinology | pmid:16131814 |
Mechoulam R and Deutsch DG | Toward an anandamide transporter. | 2005 | Proc. Natl. Acad. Sci. U.S.A. | pmid:16314567 |
Ligresti A et al. | Endocannabinoid metabolic pathways and enzymes. | 2005 | Curr Drug Targets CNS Neurol Disord | pmid:16375679 |
Flygare J et al. | Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. | 2005 | FEBS Lett. | pmid:16337199 |
Sarnataro D et al. | Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. | 2005 | FEBS Lett. | pmid:16263116 |
Van Sickle MD et al. | Identification and functional characterization of brainstem cannabinoid CB2 receptors. | 2005 | Science | pmid:16224028 |
Lee MG et al. | Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung. | 2005 | Br. J. Pharmacol. | pmid:16056239 |
Movahed P et al. | Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. | 2005 | Br. J. Pharmacol. | pmid:15997233 |
Movahed P et al. | Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. | 2005 | J. Biol. Chem. | pmid:16081411 |
Awumey EM et al. | Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism. | 2005 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16014613 |
Solbrig MV et al. | A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. | 2005 | Exp. Neurol. | pmid:16022863 |
Gaskari SA et al. | Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. | 2005 | Br. J. Pharmacol. | pmid:16025138 |
Yamaguchi Y et al. | [Surgical stress]. | 2005 | Nihon Geka Gakkai Zasshi | pmid:16045189 |
Wagner JA et al. | Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. | 2005 | J. Cardiovasc. Pharmacol. | pmid:16116341 |
McPartland JM et al. | Cannabimimetic effects of osteopathic manipulative treatment. | 2005 | J Am Osteopath Assoc | pmid:16118355 |
Schuel H and Burkman LJ | A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. | 2005 | Biol. Reprod. | pmid:16120829 |
Besana A et al. | Lipids and two-pore domain K+ channels in excitable cells. | 2005 | Prostaglandins Other Lipid Mediat. | pmid:16099395 |
van der Stelt M and Di Marzo V | Anandamide as an intracellular messenger regulating ion channel activity. | 2005 | Prostaglandins Other Lipid Mediat. | pmid:16099396 |
Patsos HA et al. | The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. | 2005 | Gut | pmid:16099783 |
Yoshihara S et al. | Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. | 2005 | Int. Arch. Allergy Immunol. | pmid:16103691 |
van der Stelt M et al. | Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. | 2005 | EMBO J. | pmid:16107881 |
Lynch DL and Reggio PH | Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics. | 2005 | J. Med. Chem. | pmid:16033262 |